Grasim Industries Ltd Q4 FY25 Earnings Analysis
Published 4 Aug 2026 | Cement & Cement Products | Market Cap: ₹2.0L Cr
Price
₹3,260
Market Cap
₹2.0L Cr
P/E Ratio
43.3
Earnings Summary
- Paints business (Birla Opus) aims to exit FY '25 with high single-digit market share and expects to do better than mid-single digits (around 5%) by March 2025. - Paints business aims to exit FY '25 with high single-digit market share and expects mid-teens market share in FY '26, indicating continued growth and market share gains.
📊 Revenue & Sales Performance
- Paints business (Birla Opus) aims to exit FY '25 with high single-digit market share and expects to do better than mid-single digits (around 5%) by March 2025. - Next year (FY '26), the paints segment targets continued quarter-on-quarter market share gains, potentially reaching mid-teens market share levels. - Birla Opus expects double-digit growth over the next decade, supported by new capacity plants coming online at Chamarajanagar, Mahad, and Kharagpur. - The building materials segment (UltraTech) is on track to reach over 200 million tons per annum domestic gray cement capacity by FY '27 with improving demand across individual house building, infrastructure, and urban housing sectors. - The Chemicals division anticipates capacity utilization improvements and steady demand, with ongoing investments like the ₹1,350 crore Lyocell specialty fiber expansion. - Overall, Grasim targets sustained sales growth, with a historical 13.5% CAGR over the past 4 years and continued revenue growth for the 17th consecutive quarter.
📈 Profitability & Margins
- Paints business aims to exit FY '25 with high single-digit market share and expects mid-teens market share in FY '26, indicating continued growth and market share gains. (Page 14) - Paints division is on track to break even within 3 years of full-scale operation, with operating losses in FY '25 as planned and expected to reduce gradually as sales ramp up. (Page 8) - Chemical segment sees steady demand and potential for price improvement due to high capacity utilization (~89%-100%) despite raw material cost pressures; ongoing capex of ₹1,350 crores in Lyocell specialty fiber expected to add value. (Pages 6-7) - CSF (Cellulosic Fiber) segment maintains stable earnings with growing demand and price improvement; EBITDA contribution seen as stable around ₹600-700 crores range. (Page 12) - Overall, consolidated revenue shows steady 9% Y-o-Y growth with continued investments in brand, capacity expansion, and market share gains, particularly in paints and B2B e-commerce segments. (Pages 4-5) - Debt to EBITDA target maintained at 3x-3.5x, indicating financial discipline alongside growth. (Page 8)
🏗️ Capital Expenditure Plans
- **FY '25 Capex:** Nearly 90% of the capex for the Paint business is complete; 6th plant expected to be finished by Q1 FY '26, with full capex completion by Q2 FY '26. - **FY '26 Capex Guidance:** Budgeting process underway; will likely be shared in Q4 FY '25 call. - **Chemicals & Specialty Fiber:** ₹1,350 crores approved for Lyocell capacity expansion (specialty fiber) at Harihar plant; total capacity to increase by 110,000 tons in two phases of 55,000 tons each. - **Focus Areas:** Continued capital allocation to CSF (Chemicals, Specialty Fibers) segment for growth; Paints capacity expansion is committed and will continue with no change. - **Debt Management:** Net debt to EBITDA planned to be maintained within 3x to 3.5x, with capex plans aligned accordingly. - **Strategic Stance:** Long-term commitment to capacity expansions, especially in Paints and Specialty Fibers, despite market fluctuations.
💰 Fundraising & Capital Structure
- Grasim Industries is planning significant capital expenditure, including ₹1,350 crores for the CSF (Chemical and Specialty Fibres) division expansion in FY '26. - Paints business capex is nearly completed, with 90% done and the 6th plant expected by Q1 FY '26. - The company aims to maintain a net debt-to-EBITDA ratio within 3x to 3.5x, indicating a cautious approach to leverage. - No explicit mention of new equity fundraising in the current call. - Debt levels and capex plans are managed carefully to avoid breaching the net debt/EBITDA threshold. - Overall, Grasim appears committed to funding expansions primarily through internal accruals and controlled debt, with no clear indication of new debt or equity fundraising imminently.
📋 Order Book & Pipeline
The transcript on page 15 from Grasim Industries Limited's Q3 FY25 earnings call does not explicitly mention the current or expected order book or pending orders. However, some related insights include: - Institutional segment orders for paints are growing with new listings underway, indicating a build-up in institutional demand. - The B2B E-commerce business, Birla Pivot, is expanding its product categories and revenue, signaling increasing order intake in the building materials segment. - The paints business is gaining market share consistently with high single-digit growth expected by March, suggesting steady demand momentum. - The chemical and CSF segments are operating near full capacity, implying healthy demand and order flow. - No specific quantitative details on order backlog or pending orders were disclosed in the Q&A on pages 14-15.
Key Metrics
Frequently Asked Questions
What were Grasim Industries Ltd Q4 FY25 results?
- Paints business (Birla Opus) aims to exit FY '25 with high single-digit market share and expects to do better than mid-single digits (around 5%) by March 2025. - Paints business aims to exit FY '25 with high single-digit market share and expects mid-teens market share in FY '26, indicating continued growth and market share gains.
What is Grasim Industries Ltd share price analysis?
Grasim Industries Ltd currently shows a neutral. The stock trades at a P/E of 43.3 with a market cap of ₹199,652. Investors should review the full earnings analysis for detailed insights.
Is Grasim Industries Ltd planning capital expenditure?
- **FY '25 Capex:** Nearly 90% of the capex for the Paint business is complete; 6th plant expected to be finished by Q1 FY '26, with full capex completion by Q2 FY '26.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
